Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms.

Niclas C BlessinPatrick SpriestersbachWenchao LiTim MandelkowDavid DumRonald SimonClaudia Hube-MaggFlorian LutzFlorian ViehwegerMaximillian LennartzChristoph FrauneVera NickelsenWilfried FehrleCosima GöbelSören WeidemannTill ClauditzPatrick LebokKatharina MöllerStefan SteurerJacob R IzbickiGuido SauterSarah MinnerFrank JacobsenAndreas M LuebkeFranziska BüscheckDoris HöflmayerWaldemar WilczakEike BurandtAndrea Hinsch

Published in: Cellular oncology (Dordrecht) (2020)

These data support the concept that among most tumor types at least some individual cancers may benefit from treatment with immune checkpoint inhibitors.

Keyphrases

endothelial cells
risk factors
electronic health record
peripheral blood
induced pluripotent stem cells
big data
machine learning
young adults
combination therapy
artificial intelligence
nk cells
replacement therapy
smoking cessation